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Available online 2 October 2016Peripheral blood was collected from a clinically characterized female Kleefstra syndrome patient with a
heterozygous, de novo, premature termination codon (PTC) mutation (NM_024757.4(EHMT1):c.3413GNA;
p.Trp1138Ter). Peripheral blood mononuclear cells (PBMCs) were reprogrammed with the human OSKM
transcription factors using the Sendai-virus (SeV) delivery system. The pluripotency of transgene-free iPSC line
was veriﬁed by the expression of pluripotency-associatedmarkers and by in vitro spontaneous differentiation to-
wards the 3 germ layers. Furthermore, the iPSC line showed normal karyotype. Our model might offer a good
platform to study the pathomechanism of Kleefstra syndrome, also for drug testing, early biomarker discovery
and gene therapy studies.
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Peripheral blood was collected from a 11-year-old female patient
with Kleefstra syndrome (KS) diagnosed by targeted next generation
sequencing (Bock et al., 2016). The diagnosis was conﬁrmed by Sanger
sequencing and by clinical evaluation of the patient. The patient pheno-
type includes autism, normal intellectual performance, developmental
delay, childhood hypotonia and facial dysmorphisms. The patient
carries a heterozygous, de novo, PTC (Trp1138Ter) mutation in the
Euchromatic histone lysine methyltransferase 1 (EHMT1) gene, which
leads to haploinsufﬁciency and causes KS (Bock et al., 2016). To gener-
ate the BIOT-0708-EHMT1 iPSC line (Fig. 1A) the PBMCs were
reprogrammed by the four “Yamanaka factors” OCT3/4, SOX2, KLF4,
and C-MYC using the integration-free Sendai virus gene-delivery meth-
od (Yang et al., 2008; Fusaki et al., 2009). The iPSC-like colonies were
picked 20–27 days post-transduction. The absence/presence of SeV
expression in the iPSCs was monitored from passage 5 by SeV-speciﬁc
RT-PCR (Table 1). After 7 passages, the transgene-free status of the
BIOT-0708-EHMT1 iPSC line was conﬁrmed and selected for further
analysis (Fig. 1B).
Expression of pluripotencymarkers was examined by alkaline phos-
phatase staining (AP) and by immunocytochemistry staining (ICC)
using antibodies against human OCT3/4, NANOG and E-CADHERIN
(Fig. 1A). The in vitro spontaneous differentiation potential of the
BIOT-0708-EHMT1 iPSC line towards the three germ layers wasthe CC BY license
CB
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Fig. 1. Characterisation of BIOT-0708-EHMT1 hiPSC line. A) Above:morphology of generated hiPSC (4×) and representative immunoﬂuorescentmicrographs of iPSC positive for stem cell
markers OCT3/4, NANOGandE-CADHERIN (in green), nucleuswas labelledwith DAPI (in blue), the iPSC line showed alkaline phosphatase activity (AP). Below: spontaneously formedEBs
(Day 5) and their further differentiation in adherent culture (Day 14). ICC for endodermal (GATA4), mesodermal (BRACHYURY) and ectodermal (βIII-TUBULIN) germ layers markers (in
green), nucleus was labelled with DAPI (in blue). B) RT-PCR veriﬁcation of the absence of Sendai-virus expression in the iPSC line and karyogram showing normal 46 chromosomes (XX).
C) Sanger sequencing of the region containing the NM_024757.4(EHMT1):c.3413GNA SNV in the newly established iPSC line.
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(BRACHYURY) and ectodermal (βIII-TUBULIN) markers (Fig. 1A)
(Itskovitz-Eldor et al., 2000; Carpenter et al., 2003).
The karyotype of the BIOT-0708-EHMT1 iPSC line was determined
with Giemsa-banding, proving normal diploid 46, XX karyotype, with-
out any detectable abnormalities (Fig. 1B). In parallel, the pathogenic
NM_024757.4(EHMT1):c.3413GNAmutation was conﬁrmed by Sanger
sequencing in the newly established iPSC line (Fig. 1C).
Materials and methods
Reprogramming of peripheral blood mononuclear cells (PBMC)
PBMCs were isolated using the Vacutainer® CPT™ Cell Preparation
Tube with Sodium Heparin (BD Biosciences). PBMCs were seeded
(0.5 × 106 cells) in ExpansionMedium (EM): QBSF-60medium (Quality
Biological) supplemented with 50 μg/ml Ascorbic acid, 1% Pen/Strep, 50
ng/ml SCF (R&D systems), 10 ng/ml IL-3 (R&D systems), 2 U/ml EPO
(R&D systems), 40 ng/ml IGF-1 (R&D systems) and 1 μM Dexametha-
sone. Nine days later (Day 0) the cells were transduced by CytoTune®-
iPS 2.0 Sendai Reprogramming Kit (Thermo Fisher Scientiﬁc), following
the manufacturer's instructions. Brieﬂy, the cells were transduced on
1w/24wp in 1 ml EM supplemented with 4 μg polybrene. Sendai-virus
(SeV) was added to the cells using MOI of 5-5-3 (KOS MOI = 5, hc-
Myc MOI = 5, hKlf4 MOI = 3). The following day the cells werecollected, centrifuged (300 rcf, 5 min, RT) and seeded in fresh EM
(Day 1). Two days later (Day 3) the cells were passed onto a 6 cm dish
covered with 0.1% gelatine and 0.65 × 106 Mitomycin C treated-MEF
in QBSF-60 medium (Quality Biological) supplemented with 50 μg/ml
Ascorbic acid. Seven days post-transduction (Day 7) the medium was
replaced with HESC medium: DMEM/F12, 20% KOSR, 1% MEM NEAA,
0.1mM β-mercaptoethanol, 0.5% Pen/Strep, 10 ng/ml bFGF and supple-
mented with 50 μg/ml Ascorbic acid. The colonies with ES-like appear-
ance were manually isolated between Day 21 to Day 27 post-
transduction and cultured as iPSCs thereafter. Human iPSC cultures
were maintained on plates coated with Matrigel (BD Biosciences) in
mTeSR-1 medium (Stem Cell Technologies) following the manufac-
turer's instructions (Fig. 1A). All cells were cultured at 37 °C in humidi-
ﬁed atmosphere containing 5% CO2.Reverse transcription polymerase chain reaction (RT-PCR)
Total RNA was isolated from cultured cells with RNeasy Micro Kit
(Qiagen) and reverse transcribed corresponding to SuperScript III Re-
verse Transcriptase protocol (Thermo Fisher Scientiﬁc). The RT-PCR re-
action was performed using GoTaq Hot Start Green Master Mix
(Promega). To conﬁrm the transgene-free status of the iPSC lines, SeV
speciﬁc primers were used as described in CytoTune®-iPS 2.0 Sendai
Reprogramming Kit protocol (Thermo Fisher Scientiﬁc; Table 1).
Table 1
Primers used in the study.
Gene symbol Nucleotide change Protein change Fwd and Rvs primers (5′–3′) PCR product (bp)
EHMT1 c.3413GNA (NM_024757.4) p.Trp1138Ter AGATGCCGTGTCTGTGAGGT
CGCCTTCTTAAATGCACTCC
469
SeV – – GGATCACTAGGTGATATCGAGC
ACCAGACAAGAGTTTAAGAGATATGTATC
181
RPS18 – – TTAAGGGTGTGGGCCGAAGA
GGGATCTTGTACTGGCGTGGA
142
Table 2
Antibodies used for immunocytochemistry.
Antibody Dilution Company (Cat #)
Pluripotency Mouse anti-E-CADHERIN 1:1000 Thermo Fisher Scientiﬁc (13-1700)
Mouse anti-OCT4 1:50 Santa Cruz Biotechnologies (sc-5279)
Goat anti-hNANOG 1:50 R&D (AF1997)
In vitro differentiation Rabbit anti-β-III-TUBULIN 1:2000 Covance (PRB-435P)
Rabbit anti-BRACHYURY T 1:50 Santa Cruz Biotechnologies (sc-20109)
Mouse anti-GATA4 1:50 Santa Cruz Biotechnologies (sc-25310)
Secondary antibodies Alexa Fluor 488 donkey anti-goat IgG 1:2000 Thermo Fisher Scientiﬁc (A-11055)
Alexa Fluor 488 donkey anti-mouse IgG 1:2000 Thermo Fisher Scientiﬁc (A-21202)
Alexa Fluor 488 donkey anti-rabbit IgG 1:2000 Thermo Fisher Scientiﬁc (A-21206)
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The iPSCs were harvested according to the mTeSR-1 kit protocol
(StemCell Technologies) and the cell clumpswere plated on lowattach-
ment dishes in mTeSR-1 medium. Five days later the embryoid bodies
(EBs) that had formed were plated on 24-well plates containing cover
slips (3–4 EBs/well), covered with 0.1% gelatin in differentiation medi-
um: DMEM, 20% FBS, 1% MEM Non-Essential Amino Acid Solution,
0.1 mM β-mercaptoethanol, 1% Pen/Strep. The medium was changed
in every second day hereafter. The cells were ﬁxed on Day 14 of differ-
entiation with 4% PFA for ICC staining speciﬁc for the 3 germ layers
(Table 2).
Immunocytochemistry (ICC)
The expression of speciﬁc pluripotency and germ layer markers
were analysed using conventional ICC staining. Cells were ﬁxed in 4%
PFA (20 min, RT), permeabilized with 0.1% Triton X-100 (5 min, RT)
and blocked in 1% bovine serum albumin (1 h, RT). The cells were incu-
bated with primary antibodies (overnight at 4 °C) and visualized with
secondary antibodies. For nuclei counterstaining 0.2 μg/ml DAPI
(20 min, RT) was used. The antibodies and applied dilutions are listed
in Table 2. The cells were observed under ﬂuorescent microscope
equipped with 3D imaging module (Axio Imager system with
ApoTome; Carl Zeiss) controlled by AxioVision 4.8.1 microscope soft-
ware (Carl Zeiss).
Alkaline phosphatase (AP) staining
For detecting alkaline phosphatase activity the 4% PFA ﬁxed cells
(20 min, RT) were stained with AP solution (29.7 mM TRIS base;
6 mMmaleic acid, pH 8.5–9.0; with 0.08% MgCl2, 10.8 mM Naphtol-As
MX Phosphate; 23 μM Fast Red TR Salt; all from Sigma Aldrich) for 30
min (RT). Samples were observedwith Axio Imager system (Carl Zeiss).
Karyotyping
Cells were treated with KaryoMAX® Colcemid™ Solution (Thermo
Fisher Scientiﬁc) and processed with standard methods. Giemsa-banded karyotype analysis was performed and a minimum of 20 meta-
phases were evaluated. The chromosomes were classiﬁed according to
the International System for Human Cytogenetic Nomenclature (ISCN).
Sanger sequencing
To conﬁrm the presence of the pathogenic EHMT1 SNV in the newly
established iPS cell line PCR primers amplifying the region of interest
were used (Bock et al., 2016; Table 1). PCR reactions were performed
using Phusion Hot Start II High-Fidelity DNA Polymerase (Thermo Fish-
er Scientiﬁc) and BIOT-0708-EHMT1 iPSC gDNAas the template. PCR re-
actions were puriﬁed with the PCR extract mini Kit (5PRIME, Hamburg,
Germany). Speciﬁc PCR products were sequenced directly using an ABI
Prism3130xlGenetic Analyzer (Applied Biosystems) andBigDye Termi-
nator Cycle Sequencing v3.1 Kit (Applied Biosystems).
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